Reducing pathological symptoms, serum IgE, the number of eosinophils in blood, and the infiltration of MC, CD86+, and CD206+ cells in skin lesions. Decreasing IL-4, IL-23, IL-31, and TNF-α in AD skin lesions. The gene discussed is MRC1; the disease is Alzheimer disease.